As of 2026-09-25, the Intrinsic Value of Cerevel Therapeutics Holdings Inc (CERE) is -12.64 USD. This CERE valuation is based on the model Peter Lynch Fair Value. With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is -128.11%.
Based on its market price of 44.96 USD and our intrinsic valuation, Cerevel Therapeutics Holdings Inc (CERE) is overvalued by 128.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.64 - -12.64 | -12.64 | -128.11% |
| P/E | (63.44) - (63.69) | (60.66) | -234.9% |
| DDM - Stable | (25.20) - (236.21) | (130.70) | -390.7% |
| DDM - Multi | (1.45) - (10.84) | (2.58) | -105.7% |
| Market Cap (mil) | 8,191.26 |
| Beta | 1.22 |
| Outstanding shares (mil) | 182.19 |
| Enterprise Value (mil) | 8,208.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.99% |
| Cost of Debt | 5.00% |
| WACC | 7.87% |